640
Participants
Start Date
September 30, 2011
Primary Completion Date
December 31, 2015
Study Completion Date
May 31, 2016
TH-302 in Combination with Doxorubicin
"300 mg/m2 of TH-302 will be administered by IV infusion over 30-60 minutes on Days 1 and 8 of a 21-day cycle.~Doxorubicin may be delivered as a bolus administration or as a continuous infusion administration; administration schedule must be specified prior to enrollment.~Doxorubicin bolus administration: 75 mg/m2 administered by bolus injection starting on Day 1 of a 21-day cycle.~Doxorubicin continuous administration: 75 mg/m2 administered by continuous IV infusion over 48-96 hours starting on Day 1 of a 21-day cycle.~Doxorubicin administration will start between 2 to 4 hours after completion of the TH-302 infusion when used in combination with TH-302."
Doxorubicin
"Doxorubicin may be delivered as a bolus administration or as a continuous infusion administration; administration schedule must be specified prior to enrollment.~Doxorubicin bolus administration: 75 mg/m2 administered by bolus injection starting on Day 1 of a 21-day cycle.~Doxorubicin continuous administration: 75 mg/m2 administered by continuous IV infusion over 48-96 hours starting on Day 1 of a 21-day cycle."
University Hospital Herlev at Copenhagen, Herlev
Universitaire Ziekenhuizen (UZ) Leuven - Gasthuisberg, Leuven
Memorial Sloan-Kettering Cancer Center, New York
Columbia University Medical Center, New York
Fondazione del Piemonte per l'Oncologia, Instituto per la Ricerca e la Cura del cancro (I.R.C.C.), Dipartimento Oncologico, Direzione Operativa Oncologia Medica a Direzione Universitaria, Candiolo
ASL TO/2 di TORINO_Presidio Sanitario Gradenigo, S.C. di Oncologia, Torino
Montefiore, The Bronx
Département d'Oncologie Moléculaire, Institut Paoli-Calmettes (IPC) and U119 Inserm, Marseille
HELIOS Klinikum Berlin-Buch, Berlin
Roswell Park Cancer Institute, Buffalo
University of Pittsburg Medical Center, Pittsburgh
Helios Klinikum Bad Saarow, Department of Hematology, Oncology, and Palliative Care, Sarcoma Center Berlin-Brandenburg, Berlin
Pennsylvania Oncology Hematology Associates, Philadelphia
Fox Chase Cancer Center, Philadelphia
Georgetown University Hospital, Washington D.C.
Washington Cancer Institute, Washington D.C.
Departement d'Oncologie Medicale, Dijon
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore
Virginia Commonwealth Universtiy-Massey Cancer Center, Richmond
Wake Forest University Baptist Medical Center, Winston-Salem
Duke University Medical Center, Durham
Hospital Universitario Ramón y Cajal., Madrid
Universidad Complutense Madrid Facultad de Medicina - Hospital Universitario 12 de Octubre, Servicio de Oncologia Medica Hospital Universitario 12 de Octubre, Madrid
Carolinas Hematology-oncology Associates-Blumenthal Cancer Center, Charlotte
MUSC - Hollings Cancer Center, Charleston
Winship Cancer Institute of Emory University, Midtown Campus, Atlanta
Medizinische Hochschule Hannover (MHH) - Klinik fuer Haemonstaseologie, Onkologie und Stammzelltransplantation, Hanover
Institut Claudius Regaud, Toulouse
Mayo Clinic-Florida-Cancer Clinical Studies Unit, Jacksonville
MD Anderson Cancer Center Orlando, Orlando
Institut Bergonie, Bordeaux
IRCCS Centro di Riferimento Oncologico-Struttura Operativa, Aviano
Centro di Riferimento Oncologico (CRO), Aviano
South Florida Center for Gynecologic Oncology, Boca Raton
H.Lee Moffitt Cancer Center and Research Institute, Tampa
Vanderbilt-Ingram Cancer Center, Nashville
H.U. Canarias, Hospital Universitario de Canarias. Servicio de Oncología Médica, Santa Cruz de Tenerife
The Arthur G. James Cancer Hospital and Richard J Solove Research Institue, The Ohio State University Comprehensive Cancer Center, Columbus
University Hospitals Seidman Cancer Center, Cleveland
Cleveland Clinic Foundation, Cleveland
ICO Rene Gauducheau, Saint-Herblain
Universitätsklinikum Essen, Essen
Indiana University Simon Cancer Center, Indianapolis
University of Michigan Cancer Center, Ann Arbor
Wilhelm's University, Universitatsklinikum Muenster, Medizinische Klinik und Poliklinik A, Albert-Schweitzer-Campus 1, Münster
University of Iowa Health Care - University of Iowa Hospital, Iowa City
Medical College of Wisconsin, Milwaukee
Mayo Rochester, Rochester
Oncology Specialists, Park Ridge
Northwestern University, Chicago
Rush University Medical Center, Chicago
Washington University School of Medicine, St Louis
CHU Strasbourg, Strasbourg
Centre Leon Berard, Lyon
Kootenai Health - Kootenai Cancer Center, Coeur d'Alene
Mayo Arizona, Scottsdale
Arizona Cancer Center, Tucson
USC-Norris Comprehensive Cancer Center, Los Angeles
Azienda Ospedaliero Universitaria-Policlinico Paolo Giacco, Palermo
Sarcoma Oncology Center, Santa Monica
Sharette Institute of Oncology, Hadassah-Hebrew University Medical Center, Hadassah Medical Org-Ein Karem, Kiryat Hadassah
Stanford Comprehensive Cancer Center, Stanford
Azienda Ospedaliera Garibaldi, Catania
Oregon Health and Science University, Portland
University of Washington Cancer Center, Seattle
ROTSN RAMS them. Н.Н.Блохина NN Blokhin, Moscow
FGU Moscow Research Institute of Oncology named after P.A. Hertzen of Rosmedtechnology, Moscow
"GUZ Regional Oncology Dispensay, Kazan", Kazan'
University of California, Los Angeles, Los Angeles
Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology, Boston
University of Vermont, Burlington
University Klinikum Graz, Graz
Univ. Klinik fur Innere Medizin I Internistische Onkologie Medizinische Universitat Innsbruck, Innsbruck
Allgemeines Krankenhaus Wien, Vienna
Juravinski Cancer Centre at Hamilton Health Sciences - Department of Medicine, Hamilton
McGill University Health Centre, Montreal
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
Ottawa Health Research Institue, Ottawa
BCCA- Vancouver Cancer Centre - Division of Medical Oncology, Vancouver
Cancer Care Manitoba, Winnipeg
Centre Antoine Lacassagne, Nice
Krankenhaus Nordwest GmbH, Frankfurt
Div. of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, Mannheim
Magyar Honvedseg Honvedkorhaz, Onkologiai Osztaly, Budapest
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Megyei Onkologiai Kozpont, Szolnok
Wojewodzkie Centrum Onkologii, Gdansk
Centrum Onkologii Instytut im M. Sklodowskiej-Curie, Krakow
Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie, Warsaw
Hospital de la Santa Creu i Sant Pau, Barcelona
Institut Catala d'Oncologia, Barcelona
Hospital Sant Joan de Deu, Department de Oncologia, Barcelona
Lead Sponsor
Sarcoma Alliance for Research through Collaboration (SARC)
UNKNOWN
Threshold Pharmaceuticals
INDUSTRY